Patient goals and preferences matter considerably
While nausea, vomiting, and diarrhea are common with semaglutide therapy, severe or persistent symptomsparticularly if they differ from your usual experienceshould be evaluated
In the STEP-1 trial, 1,961 patients were followed for 68 weeks and underwent randomization to semaglutide or placebo plus lifestyle intervention resulting in14.9% weight loss in the semaglutide group versus 2.5% in the placebo group [33]
Applying patches to skin that is damp, oily, or covered with lotion creates a barrier that prevents proper contact and may lead to premature detachment or inconsistent medication delivery
This binding signals to the brain that there is no need to eat, which triggers the feeling of satiety
Write the date you first used the pen on the label or carton so you do not lose track